Canertinib

CHF 60.00
In stock
SYN-1030-M0011 mgCHF 60.00
SYN-1030-M0055 mgCHF 78.00
SYN-1030-M01010 mgCHF 84.00
SYN-1030-M05050 mgCHF 311.00
SYN-1030-M100100 mgCHF 515.00
 
More Information
Product Details
Synonyms CI1033; PD-183805
Product Type Chemical
Properties
Formula C24H25ClFN5O3
MW 486.0
CAS 267243-28-7
Purity Chemicals ≥95%
Appearance Solid.
Solubility Soluble in DMSO or ethanol.
Declaration Manufactured by SynKinase.
Other Product Data Target: EGFR | Kinase Group: RTK | Substrate: Tyrosine

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.
InChi Key OMZCMEYTWSXEPZ-UHFFFAOYSA-N
Shipping and Handling
Shipping AMBIENT
Short Term Storage +4°C
Long Term Storage -20°C
Use/Stability Stable for at least 2 years after receipt when stored at -20°C.
Documents
MSDS Download PDF
Product Specification Sheet
Datasheet Download PDF
Canertinib is an orally bio-available EGFR inhibitor with potential anti-neoplastic and radio-sensitizing activities. It has IC(50) values of 1.5nM and 9.0nM against EGFR and ErbB2 respectively, with no activity against PDGFR, FGFR, InsR, PKC, or CDK1/2/4.
Product References
  1. The HER tyrosine kinase inhibitor CI1033 enhances cytotoxicity of 7-ethyl-10-hydroxycamptothecin and topotecan by inhibiting breast cancer resistance protein-mediated drug efflux: C. Erlichman, et al.; Cancer Res. 61, 739 (2001)
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.